Tumour progression and metastasis

被引:54
|
作者
Arvelo, Francisco [1 ,2 ]
Sojo, Felipe [1 ,2 ]
Cotte, Carlos [2 ]
机构
[1] Fdn Inst Estudios Avanzado IDEA, Ctr Biociencias, Apartado 17606, Caracas 1015A, Venezuela
[2] Cent Univ Venezuela, Inst Biol Expt, Lab Cult Tejidos & Biol Tumores, Apartado 47114, Caracas 1041A, Venezuela
来源
ECANCERMEDICALSCIENCE | 2016年 / 10卷
关键词
cancer; infiltration; metastasis; microenvironment; metastatic niche; latency; epithelial-mesenchymal transition;
D O I
10.3332/ecancer.2016.617
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The two biological mechanisms that determine types of malignancy are infiltration and metastasis, for which tumour microenvironment plays a key role in developing and establishing the morphology, growth and invasiveness of a malignancy. The microenvironment is formed by complex tissue containing the extracellular matrix, tumour and non-tumour cells, a signalling network of cytokines, chemokines, growth factors, and proteases that control autocrine and paracrine communication among individual cells, facilitating tumour progression. During the development of the primary tumour, the tumour stroma and continuous genetic changes within the cells makes it possible for them to migrate, having to count on a pre-metastatic niche receptor that allows the tumour's survival and distant growth. These niches are induced by factors produced by the primary tumour; if it is eradicated, the active niches become responsible for activating the latent disseminated cells. Due to the importance of these mechanisms, the strategies that develop tumour cells during tumour progression and the way in which the microenvironment influences the formation of metastasis are reviewed. It also suggests that the metastatic niche can be an ideal target for new treatments that make controlling metastasis possible.
引用
收藏
页数:25
相关论文
共 50 条
  • [31] Revisiting the canonical tumour progression model
    Ansieau, S.
    Hinkal, G.
    Morel, A-P
    Puisieux, A.
    PATHOLOGIE BIOLOGIE, 2011, 59 (06): : 294 - 297
  • [32] Cadherins and the tumour progression: is it all in a switch?
    Cavallaro, U
    Schaffhauser, B
    Christofori, G
    CANCER LETTERS, 2002, 176 (02) : 123 - 128
  • [33] Heparan Sulfate Proteoglycans, Tumour Progression and the Cancer Stem Cell Niche
    Haupt, Larisa M.
    Griffiths, Lyn R.
    CURRENT CANCER THERAPY REVIEWS, 2009, 5 (04) : 256 - 260
  • [34] The stressful tumour environment drives plasticity of cell migration programmes, contributing to metastasis
    Nikolaou, Savvas
    Machesky, Laura M.
    JOURNAL OF PATHOLOGY, 2020, 250 (05): : 612 - 623
  • [35] Tumour-adipose tissue crosstalk: fuelling tumour metastasis by extracellular vesicles
    Robado de Lope, Lucia
    Leaman Alcibar, Olwen
    Amor Lopez, Ana
    Hergueta-Redondo, Marta
    Peinado, Hector
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2018, 372 (1737)
  • [36] New evidence for tumour embolism as a mode of metastasis
    Hart, Ian R.
    JOURNAL OF PATHOLOGY, 2009, 219 (03): : 275 - 276
  • [37] Ablation of colorectal liver metastasis: Interaction of ablation margins and RAS mutation profiling on local tumour progression-free survival
    Calandri, Marco
    Yamashita, Suguru
    Gazzera, Carlo
    Fonio, Paolo
    Veltri, Andrea
    Bustreo, Sara
    Sheth, Rahul A.
    Yevich, Steven M.
    Vauthey, Jean-Nicolas
    Odisio, Bruno C.
    EUROPEAN RADIOLOGY, 2018, 28 (07) : 2727 - 2734
  • [38] Role of extra cellular proteins in gastric cancer progression and metastasis: an update
    Abbaszadegan, Mohammad Reza
    Mojarrad, Majid
    Moghbeli, Meysam
    GENES AND ENVIRONMENT, 2020, 42 (01)
  • [39] Metastasis: an early event in cancer progression
    Hu, Yijun
    Yu, Xiya
    Xu, Guixia
    Liu, Shanrong
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (05) : 745 - 757
  • [40] The extracellular matrix in tumor progression and metastasis
    Johannes A. Eble
    Stephan Niland
    Clinical & Experimental Metastasis, 2019, 36 : 171 - 198